Journal of Innovations in Pharmaceutical and Biological Sciences https://jipbs.com/index.php/journal <div class="content-left-top" style="width: 680px; height: auto; float: left; color: #000000; font-family: 'Times New Roman'; font-size: medium; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: #f4f4f4; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"> <p style="font-family: Arial, Helvetica, sans-serif; font-size: 13px; font-weight: normal; color: #000000; margin: 0px; padding: 0px; line-height: 20px; text-align: justify;"><strong>Journal of Innovations in Pharmaceutical and Biological Sciences</strong> is a peer reviewed Open Access International Journal of best quality dedicated to various disciplines of pharmaceutical and biological Sciences. JIPBS publishes Original Research Articles, Reviews/Mini-Reviews, Opinions &amp; Perspectives, Book Reviews for the Pharmaceutical Sciences, Short Communications, and Research Notes. The aim of the Journal is to publish high quality articles and provides an opportunity to share the information among the scientists and researchers. This scientific journal includes a wide range of fields in its discipline to create a platform for the authors to make their contribution towards the journal and the editorial office promises a peer review process for the submitted manuscripts for the quality of publishing. JIPBS is quarterly journal that is publishes four issues per year. </p> </div> <div class="clear" style="clear: both; color: #000000; font-family: 'Times New Roman'; font-size: medium; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: #f4f4f4; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"> </div> en-US Fri, 15 Jul 2022 00:00:00 +0000 OJS 3.3.0.11 http://blogs.law.harvard.edu/tech/rss 60 SARS-COV-2 and female reproductive system https://jipbs.com/index.php/journal/article/view/423 <p style="text-align: justify;">Virus SARS-CoV-2, which causes COVID-19 infection, is transmitted mainly by respiratory droplets and its clinical manifestations vary according to the severity of the disease. The respiratory system is the most affected, but other possible forms of transmission are hypothesized. SARS-CoV-2 enters the cell through the binding of the spike protein of the virus with the ACE2 receptor (angiotensin-converting enzyme 2), but it can also be mediated by proteases or cathepsins. The aim of this study is to evaluate the relationship between the COVID-19 virus and the female reproductive system, and to investigate the possibility of transmission of SARS-CoV-2 through the vaginal fluid. A literature review was carried out in the PubMed, Scielo and Web of Science databases, using the terms: “covid and female genitourinary tract”, “covid and cervical sample”, “covid and HPV”, “covid and intraepithelial lesions”, “covid and female genital tract”. Despite the few reports on the subject, some of them point to the presence of SARS-COV-2 in samples of vaginal fluid, identified by the PCR technique. Additional studies are needed in order to establish a relationship between the findings in the vaginal fluid and the correlation with infection and viral load.</p> V. Marcon Giudice, L. Cervieri Mezzomo, S. Krolow, S. Spalding, A. Mezzari, L. Noal Calil Copyright (c) 2022 https://jipbs.com/index.php/journal/article/view/423 Fri, 15 Jul 2022 00:00:00 +0000